GP-TRZ — 10mg

GP-TRZ is a synthetic dual GIP/incretin receptor agonist analog studied in biochemical research for dual incretin receptor binding and selectivity assays.

$94.99

Technical Overview GP-TRZ is a synthetic 39-amino-acid dual GIP and incretin receptor agonist analog with a fatty-acid side chain. In biochemical research settings, this peptide is frequently investigated for its role in dual incretin receptor binding and receptor-selectivity studies in cell-culture assays. GP-TRZ is synthesized and purified to research-use analytical standards suitable for controlled laboratory investigation. This material is prepared using established synthesis and purification methods, with purity assessed by HPLC to a level suitable for research and assay use. Its lyophilized (freeze-dried) powder in a sealed research vial format supports stable handling, storage, and preparation in controlled scientific environments. Composition • Listed as: GP-TRZ • C225H348N48O68 · 4,813 g/mol • Appearance: white to off-white lyophilized (freeze-dried) powder in a sealed research vial • Stated purity: ≥99.2% by HPLC Handling and storage • Sealed containers ship at ambient temperature and are stable in transit • For laboratory storage, keep the sealed material cold and protected from light and moisture • Lot expiry and release status are printed on the label and mirrored on the lot record Documentation • Every released lot carries a lot-specific Certificate of Analysis identified by internal lot number • Match the lot number on the label to the lot number on the report to connect the material in hand to its results • Reports are retained online and reachable through the container QR code For Research Use Only. Not a drug, supplement, food, or medical device. Not for human or veterinary use, diagnostic use, or any therapeutic application.